Efficacy and safety of oxiracetam in patients with vascular cognitive impairment: A multicenter, randomized, double-blinded, placebo-controlled, phase IV clinical trial.
Lim JS, Lee J, Kang Y, Park HT, Kim DE, Cha JK, Park TH, Heo JH, Lee KB, Park JM, Oh MS, Kim EG, Chang DI, Heo SH, Park MS, Park H, Yi S, Lee YB, Park KY, Lee SJ, Kim JG, Lee J, Cho KH, Rha JH, Kim YI, Lee JH, Choi JC, Oh KM, Kwon JH, Kim C, Park JH, Jung KH, Sung SM, Chung JW, Lee YS, Kim HY, Cho HJ, Park JW, Moon WJ, Bae HJ.
Lim JS, et al. Among authors: park ky, park jh, park jw, park ht, park h, park ms, park th, park jm.
Contemp Clin Trials. 2023 Mar;126:107108. doi: 10.1016/j.cct.2023.107108. Epub 2023 Jan 29.
Contemp Clin Trials. 2023.
PMID: 36724841
Clinical Trial.